Egide: Exit from the "Penalty Bench" compartment as of July 2nd, 2025
Bollène (France), July 1st, 2025 – 06 :00pm (CET)
Press Release
Return to normal trading on
Euronext Growth Paris™
Exit from the "Penalty Bench" compartment as of July 2nd, 2025
Egide Group (Euronext Growth Paris™- ISIN: FR0000072373 - Ticker: ALGID), worldwide provider of hermetic packages and connectors and heat dissipation solutions for sensitive electronic components, announces that its shares will return to normal trading as of July 2nd, 2025.
Following the publication of its 2024 Annual Financial Report on June 30, 2025, Euronext has confirmed to the Egide Group the return of its shares to the standard trading group, ending the temporary transfer to the "Penalty Bench" compartment since May 16, 2025.
This normalization allows shareholders and investors to conduct their transactions again under normal conditions, without restriction from any account-holding institution.
The Egide Group thanks its shareholders and investors for their continued confidence during this transitional period.
FINANCIAL CALENDAR
2025 HY Revenue: July 30, 2025
Combined General Meeting: September 10, 2025 – 11:00 am at the head office in Bollène
2025 HY Results: October 20, 2025
CONTACTS
EGIDE David HIEN CEO +33 4 90 30 35 98 dhien@fr.egide-group.com
FIN’EXTENSO Isabelle APRILE Financial Communications Agency +33 6 17 38 61 78 i.aprile@finextenso.fr
About Egide Group – Keep up to date with all the Group’s news online: www.egide-group.com et LinkedIn
Egide is a group with an international dimension, specialized in the manufacture of hermetic packages and heat dissipation solutions for sensitive electronic components. It operates in cutting edge markets with strong technology barriers to entry in all critical industry segments (Thermal Imaging. Optronics. High-Frequency. Power Units…). Egide is the only pure player in this market niche with manufacturing bases in France and the United States.
EGIDE is listed on Euronext Growth Paris™- ISIN: FR0000072373 - Ticker: ALGID
Attachment
